Application
Western blot analysis of CD248 Antibody (C-term) in 293 cell line lysates (35ug/lane). CD248 (arrow) was detected using the purified Pab.Application
Flow cytometric analysis of 293 cells using CD248 Antibody (C-term) (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | CD248 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:50~100 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CD164L1, TEM1 |
|---|---|
| Alternative Names | CD248 CD164L1 TEM1 Endosialin Tumor endothelial marker 1 CD_antigen=CD248 Flags: Precursor |
| Molecular Weight(MW) | 80859 Da |
| Function | May play a role in tumor angiogenesis. |
| Tissue Specificity | Expressed in tumor endothelial cells but absent or barely detectable in normal endothelial cells. Expressed in metastatic lesions of the liver and during angiogenesis of corpus luteum formation and wound healing. Expressed in vascular endothelial cells of malignant tumors but not in normal blood vessels. Expressed in stromal fibroblasts |
| Cellular Localization | Membrane; Single-pass type I membrane protein (Probable) |
| Entrez Gene | 57124 |
|---|
Application
Western blot analysis of CD248 Antibody (C-term) in 293 cell line lysates (35ug/lane). CD248 (arrow) was detected using the purified Pab.
Application
Flow cytometric analysis of 293 cells using CD248 Antibody (C-term) (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:50~100 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
